Viking Therapeutics
VKTX
#2507
Rank
S$7.74 B
Marketcap
$69.47
Share price
0.19%
Change (1 day)
357.54%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$35.57 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are S$35.57 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$26.5 M-14.8%
2022-12-31S$31.11 M162.17%
2021-12-31S$11.86 M-26.22%
2020-12-31S$16.08 M67.16%
2019-12-31S$9.62 M54.39%
2018-12-31S$6.23 M-46.17%
2017-12-31S$11.57 M23.22%
2016-12-31S$9.39 M-1.06%
2015-12-31S$9.49 M-71.45%
2014-12-31S$33.26 M5990.9%
2013-12-31S$0.54 M323.6%
2012-12-31S$0.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.59 B 4,385.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.17 B 3,211.51%๐Ÿ‡บ๐Ÿ‡ธ USA